898
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Structural analysis of structurally diverse α-glucosidase inhibitors for active site feature analysis

, &
Pages 649-657 | Received 16 Jun 2011, Accepted 12 Jul 2011, Published online: 08 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

N. S. Hari Narayana Moorthy, Maria J. Ramos & Pedro A. Fernandes. (2014) Predictive QSAR models development and validation for human ether-a-go-go related gene (hERG) blockers using newer tools. Journal of Enzyme Inhibition and Medicinal Chemistry 29:3, pages 317-324.
Read now

Articles from other publishers (5)

Filipe G. A. Estrada, Silvia Miccoli, Natália Aniceto, Alfonso T. García-Sosa & Rita C. Guedes. (2021) Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma. Molecules 26:18, pages 5574.
Crossref
Narayana Subbiah Hari Narayana Moorthy. (2021) In Silico Based Structural and Fingerprint Analysis of Structurally Diverse AT1 inhibitors. Letters in Drug Design & Discovery 18:1, pages 93-103.
Crossref
Syahrul Imran, Muhammad Taha, Nor Hadiani Ismail, Syed Muhammad Kashif, Fazal Rahim, Waqas Jamil, Habibah Wahab & Khalid Mohammed Khan. (2016) Synthesis, In vitro and Docking Studies of New Flavone Ethers as α -Glucosidase Inhibitors . Chemical Biology & Drug Design 87:3, pages 361-373.
Crossref
N. S. Hari Narayana Moorthy, Nuno M. F. S. A. Cerqueira, Maria J. Ramos & Pedro A. Fernandes. (2013) Combined ligand and structure based binding mode analysis of oxidosqualene cyclase inhibitors. RSC Advances 3:45, pages 23409.
Crossref
N.S.H.N. Moorthy, Natércia F. Brás, Maria J. Ramos & Pedro A. Fernandes. (2012) Virtual screening and QSAR study of some pyrrolidine derivatives as α-mannosidase inhibitors for binding feature analysis. Bioorganic & Medicinal Chemistry 20:24, pages 6945-6959.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.